Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2007-06-26
2007-06-26
Pak, Michael (Department: 1646)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
36, C530S402000
Reexamination Certificate
active
09903876
ABSTRACT:
This invention is directed to the crystal structure of Estrogen Receptor-β (ER-β) complexed with genistein, and to the use of this structure in rational drug design methods to identify agents that may interact with active sites of ER-β, which may be useful as novel chemotherapeutic agents.
REFERENCES:
patent: 6228990 (2001-05-01), Ljunggren et al.
patent: 6476196 (2002-11-01), Ljunggren et al.
patent: 2003/0167999 (2003-09-01), Donner et al.
Bourguet, W , et al.Nature1995, 375: 377-382. “Crystal structure of the lingand-binding domain of the human nuclear receptor RXR-α”.
Brzozowski, A, et al.Nature1997, 389: 753-758.
Ding, S, et al.Mol. Endocrinol. 1998, 12: 302-313. “Nuclear Receptor-Binding Sites of Coactivators Glucocorticoid Receptor Interacting Protein 1 (GRIP1) and Steroid Receptor Coactivator 1 (SRC-1): Multiple Motifs with Different Binding Specificities”.
Evans, RM,Science1988, 240:889-895. “The Steroid and Thyroid Hormone Receptor Superfamily.”
Glass, CK et al.Curr. Opin. Cell Biol. 1997, 9: 222-232. “Nuclear receptor coactivators”.
Heery, D, et al.Nature1997, 387: 733-736. “A signature motif in transcriptional co-activators mediates binding to nuclear receptors”.
Horwitz, KB, et al.Mol. Endocrinol. 1996, 10:1167-1177. “Nuclear Receptor Coactivators and Corepressors”.
Kuiper JJGM, et al.Proc. Natl. Acad. Sci. USA1996, 93:5925-5930. “Cloning of a novel estrogen receptor expressed in rat prostate and ovary”.
Le Douarin, B, et al.EMBO J. 1996 15: 6701-6715. “A possible involvement of TIF1α and TIF1β in the epigenetic control of transcription by nuclear receptors”.
Renaud, J, et al.Nature1995, 378: 681-689. “Crystal strucutre of the RAR-γ ligand-binding domain bound to all-transretinoic acid”.
Shiau, A, et al.Cell1998, 95: 927-937. “The Structural Basis of Estrogen Receptor/Coactivator Recognition and the Antagonism of This Interaction by Tamoxifen”.
Suen, C-S, et al.J. Biol. Chem. 1998, 273: 27645-27653. “A Transcriptional Coactivator, Steroid Receptor Coativator-3, Selectively Augments Steroid Receptor Transcriptional Activity”.
Tanenbaum, DN, et al.Proc. Natl. Acad. Sci. USA1998, 95: 5998-6003. “Crystallographic comparison of the estrogen and progesterone receptor's ligand binding domain”.
Torchia, J, et al.Nature1997, 387: 677-684. “The transcriptional co-activator p/CIP bind CBP and mediates nuclear-receptor function”.
Tsai, MJ, et al.Annu. Rev. Biochem. 1994, 63:451-486. “Molecular mechanisms of action of steroid/thyroid receptor superfamily members”.
Akopian Tatos N.
Hsiao Chu-Lai
Somers William S.
Unwalla Rayomand
Xu Zhang-Bao
Fish & Richardson P.C.
Genetics Institute, LLC.
Pak Michael
LandOfFree
Method using crystal structure of estrogen receptor-β... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method using crystal structure of estrogen receptor-β..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method using crystal structure of estrogen receptor-β... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3856545